# A consumer market study conducted on “Consumer Experience with Toxin Resistance” by Frost & Sullivan across 7 Asia Pacific Countries (Australia, Hong Kong, India, Singapore, South Korea, Taiwan and Thailand) and included 2,201 Botulinum toxin users from the ages of 21 to 55 years old.
^ Excluded the patients who experienced the Boutulinum Toxin A treatment which as presence of impurities*
* Impurities refer to the presence of complexing proteins, inactive neurotoxin, flagellin and bacterial DNA contaminants.1
1 Park JY, et al. Neurotoxin impurities: A Review of threats to Efficacy. Plast Recontr Surg Glob Open. 2020;8(1):e2627